Piper Jaffray & Co. initiates coverage on Clinical Data (Nasdaq: CLDA) with an Overweight rating. Price target $25.

Piper analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE